Brief: Opsens Receives FDA Approval Of Optowire Iii
13/01/2020 14:02
Jan 13 (Reuters) - Opsens Inc OPS.TO :
* OPSENS RECEIVES FDA APPROVAL OF OPTOWIRE III
* OPSENS INC - HAS ALSO FILED APPROVAL APPLICATIONS TO
MARKET
OPTOWIRE III IN JAPAN, AND EUROPE
Source text for Eikon: ID:nCNWJhdNRa
Further company coverage: OPS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Opsens
See all newsBrief: Haemonetics Corporation Completes Acquisition Of Opsens
Brief: Opsens Receives Final Order For Arrangement With Haemonetics
Brief: Opsens Obtains Regulatory Clearance Of Arrangement In US And Canada
Brief: OpSens- Independent Proxy Advisory Firm ISS Recommends Shareholders Vote "For"
Brief: Opsens Announces Positive Clinical Results From Safe-Tavi Study With Savvywire In Europe